Letter: double‐dose intensification – a quick way to reverse antibody formation and loss of response in patients treated with adalimumab

Echarri Ana; Molina Gema; Sagastagoia Olatz; Fuster Lucía; Fraga Rebeca; Cid Javier

首页> 外文期刊>Alimentary pharmacology & therapeutics. >Letter: double‐dose intensification – a quick way to reverse antibody formation and loss of response in patients treated with adalimumab

【24h】

Letter: double‐dose intensification – a quick way to reverse antibody formation and loss of response in patients treated with adalimumab

机译：字母：双剂量强化 - 一种快速的逆向抗体形成和用达达罗单抗治疗患者的反应丧失

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Alimentary pharmacology & therapeutics. 》 |2019年第6期| 共2页
作者
Echarri Ana; Molina Gema; Sagastagoia Olatz; Fuster Lucía; Fraga Rebeca; Cid Javier;
展开▼
作者单位

GastroenterologyComplejo Hospitalario Universitario de FerrolFerrol Spain;

GastroenterologyComplejo Hospitalario Universitario de FerrolFerrol Spain;

Clinical Laboratory ServiceComplejo Hospitalario Universitario de FerrolFerrol Spain;

Servicio de FarmaciaComplejo Hospitalario Universitario de FerrolFerrol Spain;

GastroenterologyComplejo Hospitalario Universitario de FerrolFerrol Spain;

Department of ImmunologyComplejo Hospitalario Universitario de A Coru?aLa Coru?a Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Letter: double‐dose intensification – a quick way to reverse antibody formation and loss of response in patients treated with adalimumab [J] . Echarri Ana, Molina Gema, Sagastagoia Olatz, Alimentary pharmacology & therapeutics. . 2019 ,第6期

机译：字母：双剂量强化 - 一种快速的逆向抗体形成和用达达罗单抗治疗患者的反应丧失
2. Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review. [J] . Billioud V, Sandborn WJ, Peyrin Biroulet L The American Journal of Gastroenterology . 2011 ,第4期

机译：克罗恩病失去反应并需要阿达木单抗剂量加强治疗：系统评价。
3. Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment [J] . Suzuki T., Mizoshita T., Sugiyama T., Case Reports in Gastroenterology . 2019 ,第1期

机译：阿达木单抗剂量递增疗法对难治性克罗恩病，对阿达木单抗无反应的患者有效，尤其是在未接受英夫利昔单抗治疗的情况下
4. The Risk for Secondary Cancers in Patients Treated for Prostate Carcinoma - An Analysis with the Competition Dose Response Model [C] . A. Dasu, I. Toma-Dasu, L. Franzen, World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：前列腺癌患者继发癌症的风险-竞争剂量反应模型的分析
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohns Disease Patients with Loss of Response to Adalimumab Especially in Cases without Previous Infliximab Treatment [O] . Taketo Suzuki, Tsutomu Mizoshita, Tomoya Sugiyama, 2019

机译：阿达木单抗剂量递增疗法对难治性克罗恩病对阿达木单抗无反应的患者有效尤其是在未接受英夫利昔单抗治疗的情况下
7. Letter: double-dose intensification-a quick way to reverse antibody formation and loss of response in patients treated with adalimumab. Authors reply [O] . Bella Ungar, Shomron Ben Horin, Xavier Roblin 2019

机译：字母：双剂量强化 - 用催风机组治疗的患者逆转抗体形成和反应丧失的快速方法。作者回复

Letter: double‐dose intensification – a quick way to reverse antibody formation and loss of response in patients treated with adalimumab

著录项

相似文献

相关主题

期刊订阅